Masayuki Mizuno Selected Research

Masayuki Mizuno Research Topics

Disease

11	Non-alcoholic Fatty Liver Disease 08/2022 - 04/2010
9	Fibrosis (Cirrhosis) 03/2021 - 08/2015
4	Liver Cirrhosis (Hepatic Cirrhosis) 08/2022 - 05/2016
4	Heart Failure 10/2014 - 05/2013
3	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 09/2005
2	Stomach Neoplasms (Stomach Cancer) 03/2021 - 12/2012
2	Cognitive Dysfunction 08/2019 - 01/2017
2	Hypotension (Low Blood Pressure) 03/2014 - 05/2013
1	Thrombocytopenia (Thrombopenia) 08/2022
1	Bacterial Infections (Bacterial Infection) 09/2021
1	Leukocytosis (Pleocytosis) 09/2021
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 03/2021
1	Meningeal Carcinomatosis 03/2021
1	Atrophy 08/2019
1	Fatty Liver 06/2018
1	Alcoholic Fatty Liver 06/2018
1	Diverticulum 02/2018
1	Pancreatitis 02/2018
1	Infections 01/2018
1	Chronic Hepatitis C 01/2018
1	Teratoma (Teratoid Tumor) 02/2017
1	Encephalitis (Encephalitis, Rasmussen) 02/2017
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 02/2017
1	Liver Diseases (Liver Disease) 05/2016
1	Liver Neoplasms (Liver Cancer) 05/2016
1	Disease Progression 02/2016
1	Hepatitis 02/2016
1	Death (Near-Death Experience) 01/2016
1	Confusion (Bewilderment) 01/2016
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 08/2015
1	Neoplasms (Cancer) 12/2014
1	Edema (Dropsy) 01/2014
1	Wounds and Injuries (Trauma) 04/2013
1	Hyponatremia 04/2013
1	Brain Ischemia (Cerebral Ischemia) 01/2012
1	Stroke (Strokes) 01/2012
1	Thrombosis (Thrombus) 10/2010
1	Insulin Resistance 04/2010
1	Hepatitis C 12/2008
1	Ulcerative Colitis 01/2007
1	Hypersensitivity (Allergy) 01/2007
1	Churg-Strauss Syndrome (Allergic Angiitis) 10/2004
1	Cardiogenic Shock 10/2004
1	Myocardial Infarction 12/2002

Drug/Important Bio-Agent (IBA)

7	Collagen Type IV (Type IV Collagen)IBA 03/2021 - 04/2010
3	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2020
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020 - 08/2017
2	Alanine Transaminase (SGPT)IBA 01/2020 - 08/2017
2	Genetic Markers (Genetic Marker)IBA 01/2018 - 08/2015
2	Proteins (Proteins, Gene)FDA Link 02/2017 - 08/2015
2	Pharmaceutical PreparationsIBA 12/2014 - 01/2007
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2014 - 04/2013
1	Thrombopoietin (c-mpl Ligand)IBA 08/2022
1	Adenosine DeaminaseIBA 09/2021
1	GadoliniumIBA 03/2021
1	Pemetrexed (MTA)FDA Link 08/2019
1	ImmunosorbentsIBA 06/2018
1	EnzymesIBA 06/2018
1	Immunoglobulin M (IgM)IBA 06/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Hyaluronic Acid (Hyaluronan)IBA 02/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 02/2017
1	AntigensIBA 05/2016
1	acarboxyprothrombin (PIVKA)IBA 05/2016
1	Ethanol (Ethyl Alcohol)IBA 05/2016
1	Biological ProductsIBA 02/2016
1	adiponutrinIBA 08/2015
1	Phospholipases (Phospholipase)IBA 08/2015
1	Sorafenib (BAY 43-9006)FDA Link 12/2014
1	Vasodilator Agents (Vasodilators)IBA 05/2013
1	human NPPA protein (carperitide)IBA 05/2013
1	Nicorandil (SG 75)IBA 05/2013
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 04/2013
1	SodiumIBA 04/2013
1	S 1 (combination)IBA 12/2012
1	Trastuzumab (Herceptin)FDA Link 12/2012
1	Docetaxel (Taxotere)FDA Link 12/2012
1	hippocampal cholinergic neurostimulating peptideIBA 01/2012
1	Sirolimus (Rapamycin)FDA Link 10/2010
1	LDL Lipoproteins (beta Lipoproteins)IBA 04/2010
1	nasIBA 04/2010
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2007
1	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2002

Therapy/Procedure

6	Therapeutics 01/2018 - 12/2002
5	Drug Therapy (Chemotherapy) 03/2021 - 12/2008
2	Stents 02/2018 - 10/2010
2	Length of Stay 01/2016 - 09/2013
1	Salpingo-oophorectomy 02/2017
1	Cognitive Training 01/2017
1	Counterpulsation (External Counterpulsation) 10/2014
1	Catheters 03/2014
1	Drug-Eluting Stents 10/2010
1	Intra-Aortic Balloon Pumping 10/2004
1	Percutaneous Coronary Intervention 12/2002